Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Pyrimidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.34 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALPL | P05186 | 1/20 | 0.31 |
| ▸ | ALPI | P09923 | 1/20 | 0.31 |
| ▸ | ALPG | P10696 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrimidine SCHEMBL454436 | 1.00 | FDPS (0.34) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL4140222 | 1.00 | FDPS (0.34) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL988740 | 1.00 | FDPS (0.34) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL28436619 | 0.97 | FDPS (0.33) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL27748802 | 0.91 | FDPS (0.31) | FDPSBTN3A1PDE3A | |
| Pyrimidine SCHEMBL27549055 | 0.88 | FDPS (0.32) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL28663 | 0.88 | FDPS (0.32) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL27549056 | 0.88 | FDPS (0.32) | FDPSBTN3A1PDE3ATSHRNAPRT | |
| Pyrimidine SCHEMBL1880807 | 0.84 | FDPS (0.35) | FDPSBTN3A1PDE3AALPLALPI | |
| Foscarnet SCHEMBL15510548 | 0.83 | FDPS (0.33) | FDPSTSHRNAPRTTDP1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103031286-B | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2015-03-18 | — | — | CN | claimed |
| CN-103031287-B | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2014-12-10 | — | — | CN | claimed |
| CN-103045548-A | Cordyceps sinensis ribonucleotide reductase as well as coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-17 | — | — | CN | claimed |
| CN-103031287-A | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | claimed |
| CN-103031286-A | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | claimed |
| US-7612047-B2 | Degradation-resistant mononucleoside phosphate compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-11-03 | — | — | US | claimed |
| US-20090076256-A1 | DEGRADATION-RESISTANT MONONUCLEOSIDE PHOSPHATE COMPOUNDS | DOUGLASS III JAMES G | 2009-03-19 | — | — | US | claimed |
| CN-103031286-B | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2015-03-18 | — | — | CN | disclosed |
| CN-103031287-B | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2014-12-10 | — | — | CN | disclosed |
| CN-103045548-A | Cordyceps sinensis ribonucleotide reductase as well as coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-17 | — | — | CN | disclosed |
| CN-103031287-A | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | disclosed |
| CN-103031286-A | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | disclosed |
| CN-102115485-A | Prodrug based on cytosine arabinoside structure, and synthesis method and application thereof | SANLUGEN PHARMATECH | 2011-07-06 | — | — | CN | disclosed |
| CN-1217003-C | Micro array reaction apparatus and uses thereof | CAPTIAL BIOCHIP CO LTD (CN) | 2005-08-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076256-A1 | DEGRADATION-RESISTANT MONONUCLEOSIDE PHOSPHATE COMPOUNDS | PNKP, ENTPD5, ENPP1 | FDPS 184/4885BTN3A1 4600/4885PDE3A 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.